BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8411805)

  • 21. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving accuracy in the grading of renal cell carcinoma by combining the quantitative description of chromatin pattern with the quantitative determination of cell kinetic parameters.
    François C; Moreno C; Teitelbaum J; Bigras G; Salmon I; Danguy A; Brugal G; van Velthoven R; Kiss R; Decaestecker C
    Cytometry; 2000 Feb; 42(1):18-26. PubMed ID: 10679739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
    Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
    Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nucleolar organizer regions in renal cell carcinoma].
    Abe K; Masai M; Isaka S; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):642-9. PubMed ID: 8492506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
    Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
    Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma.
    Rassnick KM; Mauldin GN; Moroff SD; Mauldin GE; McEntee MC; Mooney SC
    J Vet Intern Med; 1999; 13(3):187-90. PubMed ID: 10357106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic prognostic indicators for renal cell carcinoma.
    Delahunt B
    Semin Diagn Pathol; 1998 Feb; 15(1):68-76. PubMed ID: 9503507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma.
    Pich A; Marmont F; Chiusa L; Cappello N; Resegotti L; Navone R
    Br J Haematol; 1992 Dec; 82(4):681-8. PubMed ID: 1482655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
    Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
    Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors of renal cell carcinoma: a multivariate analysis.
    Yasunaga Y; Shin M; Miki T; Okuyama A; Aozasa K
    J Surg Oncol; 1998 May; 68(1):11-8. PubMed ID: 9610657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A; Margaria E; Chiusa L
    Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of argyrophilic nucleolar organizer staining for predicting prognosis of patients with recurrent soft tissue sarcoma.
    Kuratsu S; Ohsawa M; Naka N; Myoui A; Tomita Y; Uchida A; Ono K; Aozasa K
    Oncology; 1994; 51(3):244-50. PubMed ID: 8196907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
    Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
    Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.
    Derenzini M; Sirri V; Trerè D; Ochs RL
    Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland.
    Zaczek M; Szot W; Chłap Z
    Anal Quant Cytol Histol; 1996 Feb; 18(1):1-8. PubMed ID: 8851102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.